Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic and therapeutic relevance of c-FLIP in acute myeloid leukaemia.
McLornan D, Hay J, McLaughlin K, Holohan C, Burnett AK, Hills RK, Johnston PG, Mills KI, McMullin MF, Longley DB, Gilkes A. McLornan D, et al. Among authors: hills rk. Br J Haematol. 2013 Jan;160(2):188-98. doi: 10.1111/bjh.12108. Epub 2012 Nov 20. Br J Haematol. 2013. PMID: 23167276 Free article.
Impact of karyotype on treatment outcome in acute myeloid leukemia.
Grimwade D, Moorman A, Hills R, Wheatley K, Walker H, Harrison G, Harrison Ch, Goldstone A, Burnett A; NCRI Adult Leukaemia Working Party. Grimwade D, et al. Ann Hematol. 2004;83 Suppl 1:S45-8. doi: 10.1007/s00277-004-0849-8. Ann Hematol. 2004. PMID: 15124668 Review.
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia.
Gale RE, Hills R, Pizzey AR, Kottaridis PD, Swirsky D, Gilkes AF, Nugent E, Mills KI, Wheatley K, Solomon E, Burnett AK, Linch DC, Grimwade D; NCRI Adult Leukaemia Working Party. Gale RE, et al. Blood. 2005 Dec 1;106(12):3768-76. doi: 10.1182/blood-2005-04-1746. Epub 2005 Aug 16. Blood. 2005. PMID: 16105978 Free article.
Long-term results of the MRC AML10 trial.
Burnett AK, Wheatley K, Goldstone AH, Stevens R, Hann I, Hills RK. Burnett AK, et al. Among authors: hills rk. Clin Adv Hematol Oncol. 2006 Jun;4(6):445-51. Clin Adv Hematol Oncol. 2006. PMID: 16981667 Clinical Trial. No abstract available.
Problems with up-front randomization in clinical trials.
Wheatley K, Hills RK, Burnett AK. Wheatley K, et al. Among authors: hills rk. J Clin Oncol. 2006 Dec 1;24(34):5471-2; author reply 5472-3. doi: 10.1200/JCO.2006.08.3048. J Clin Oncol. 2006. PMID: 17135654 No abstract available.
CD200 as a prognostic factor in acute myeloid leukaemia.
Tonks A, Hills R, White P, Rosie B, Mills KI, Burnett AK, Darley RL. Tonks A, et al. Leukemia. 2007 Mar;21(3):566-8. doi: 10.1038/sj.leu.2404559. Epub 2007 Jan 25. Leukemia. 2007. PMID: 17252007 No abstract available.
A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment.
Burnett AK, Milligan D, Prentice AG, Goldstone AH, McMullin MF, Hills RK, Wheatley K. Burnett AK, et al. Among authors: hills rk. Cancer. 2007 Mar 15;109(6):1114-24. doi: 10.1002/cncr.22496. Cancer. 2007. PMID: 17315155 Free article. Clinical Trial.
207 results